Questionnaire Administration
Questionnaire Administration is an intervention with 1,655 clinical trials. Currently 675 active trials ongoing. Historical success rate of 80.5%.
Success Metrics
Based on 603 completed trials
Phase Distribution
Phase Distribution
172
Early Stage
391
Mid Stage
165
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
71.4%
603 of 845 finished
28.6%
242 ended early
675
trials recruiting
1,655
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms
Acupuncture for the Management of Postoperative Pain in Patients With Pancreatic or Colorectal Cancer Undergoing Surgery
Mobile-Health Delivery of Lifestyle Interventions for Women With Breast Cancer
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Clinical Trials (1,655)
Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms
Acupuncture for the Management of Postoperative Pain in Patients With Pancreatic or Colorectal Cancer Undergoing Surgery
Mobile-Health Delivery of Lifestyle Interventions for Women With Breast Cancer
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders
Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
Impact of Dietary Inflammatory Potential on Breast Cancer Risk
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy
Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer
The Vanguard Study: Testing a New Way to Screen for Cancer
The Role of Lifestyle Factors in Breast Cancer-Related Outcomes
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Behavioral Activation Therapy and Nicotine Replacement Therapy in Increasing Smoking Cessation
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 1,655